Adalimumab-aacf

Generic name: adalimumab

Used for: Rheumatoid arthritis and juvenile arthritis (JIA) · Plaque psoriasis · Crohn’s disease · Ulcerative colitis · Psoriatic arthritis · Ankylosing spondylitis (arthritis of the spine) · Hidradenitis suppurativa (painful lumps under the skin) · Non-infectious uveitis (inflammation in the middle or back of the eye) · 7 more

How do you pay?

How to pay the least

Ask for the cash price

Adalimumab-aacf

Adalimumab-aacf is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold.

  1. Ask your pharmacy for Adalimumab-aacf’s cash price, and one or two other pharmacies too.
  2. Adalimumab-aacf’s savings card works only with insurance from a job or one you bought.

Compare every option

Question
Brand nameAdalimumab-aacf
Authorized genericadalimumab
Regular genericadalimumab
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldAsk the pharmacy
Same as Adalimumab-aacf?
The original
–
–

Brand nameThe maker’s card

KabiCare Copay Program

Savings card from Fresenius Kabi

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 a month

Sign up on kabicare.us 

Or call 1-833-522-4227.

In the maker’s words

“they may be eligible for the copay program that lowers their out-of-pocket costs to as little as $0/month for treatment with an annual maximum…”

From the maker’s offer on kabicare.us, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Adalimumab-aacf itself, from the same company, sold without the brand name, and usually for less. For now Adalimumab-aacf is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

Adalimumab-aacf is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

Adalimumab-aacf is a tumor necrosis factor (TNF) blocker indicated for:

  • Rheumatoid Arthritis (RA): reducing signs and symptoms, inducing major clinical response, inhibiting the progression of structural damage, and improving physical function in adult patients with moderately to severely active RA.
  • Juvenile Idiopathic Arthritis (JIA): reducing signs and symptoms of moderately to severely active polyarticular JIA in patients 2 years of age and older.
  • Psoriatic Arthritis (PsA): reducing signs and symptoms, inhibiting the progression of structural damage, and improving physical function in adult patients with active PsA.
  • Ankylosing Spondylitis (AS): reducing signs and symptoms in adult patients with active AS.
  • Crohn's Disease (CD): treatment of moderately to severely active Crohn's disease in adults and pediatric patients 6 years of age and older.
  • Ulcerative Colitis (UC): treatment of moderately to severely active ulcerative colitis in adult patients. Limitations of Use: Effectiveness has not been established in patients who have lost response to or were intolerant to TNF blockers.
  • Plaque Psoriasis (Ps): treatment of adult patients with moderate to severe chronic plaque psoriasis who are candidates for systemic therapy or phototherapy, and when other systemic therapies are medically less appropriate.
  • Hidradenitis Suppurativa (HS): treatment of moderate to severe hidradenitis suppurativa in adult patients.
  • Uveitis (UV): treatment of non-infectious intermediate, posterior, and panuveitis in adult patients.

Source: the FDA label for Adalimumab-aacf (Fresenius Kabi USA, LLC), January 8, 2026. Full label on DailyMed 

Good to know

Prices checked November 2, 2026. Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/adalimumab-aacf/